Abbott Laboratories Financials
| ABL Stock | EUR 107.52 2.82 2.56% |
Abbott |
Understanding current and past Abbott Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abbott Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in Abbott Laboratories' assets may result in an increase in income on the income statement.
You should never invest in Abbott Laboratories without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abbott Stock, because this is throwing your money away. Analyzing the key information contained in Abbott Laboratories' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Abbott Laboratories Key Financial Ratios
There are many critical financial ratios that Abbott Laboratories' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Abbott Laboratories reports annually and quarterly.Abbott Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abbott Laboratories's current stock value. Our valuation model uses many indicators to compare Abbott Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abbott Laboratories competition to find correlations between indicators driving Abbott Laboratories's intrinsic value. More Info.Abbott Laboratories is the top company in current valuation category among its peers. It also is number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Abbott Laboratories is about 35,209,238,840 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abbott Laboratories' earnings, one of the primary drivers of an investment's value.Abbott Laboratories Systematic Risk
Abbott Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abbott Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-six with a total number of output elements of thirty-five. The Beta measures systematic risk based on how returns on Abbott Laboratories correlated with the market. If Beta is less than 0 Abbott Laboratories generally moves in the opposite direction as compared to the market. If Abbott Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abbott Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abbott Laboratories is generally in the same direction as the market. If Beta > 1 Abbott Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
Abbott Laboratories January 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Abbott Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abbott Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abbott Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing Abbott Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abbott Laboratories's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.9768 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 6.43 | |||
| Value At Risk | (1.42) | |||
| Potential Upside | 1.41 |
Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Abbott Stock, please use our How to Invest in Abbott Laboratories guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.